Phentermine 7.5 mg / topiramate 46 mg [Qsymia]
RxNorm 1302829
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1302829 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: phentermine 7.5 mg / topiramate 46 mg [Qsymia].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDCPrescribable
Semantic Branded Drug Component (SBDC):
Phentermine 7.5 mg / topiramate 46 mg [Qsymia]
(Atom ID: 12310170)
Patient Education
Phentermine and Topiramate
Phentermine and topiramate extended-release (long-acting) capsules are used to help adults who are obese or who are overweight and have weight-related medical problems to lose weight and to keep from gaining back that weight. Phentermine and topiramate extended-release capsules must be used along with a reduced calorie diet and exercise plan. Phentermine is in a class of medications called anorectics. It works by decreasing appetite. Topiramate is in a class of medications called anticonvulsants. It works by decreasing appetite and by causing feelings of fullness to last longer after eating.
[Learn More]
* Please review the disclaimer below.